About the MRL
The Mycobacteria Research Laboratories was founded some 25 years ago by Dr. Patrick J. Brennan and colleagues with the intent of generating an internationally recognized center of excellence for the study of mycobacterial diseases and pathogens. Since then, the MRL has been at the forefront of mycobacterial fundamental and translational research. Research programs in the MRL utilize state-of-the-art techniques and facilities to address
- tuberculosis vaccine and drug development,
- leprosy and tuberculosis diagnostics,
- the study of nontuberculous mycobacterial diseases and Buruli ulcer,
- and the epidemiology and diagnostics of mycobacterial diseases affecting animals including bovine tuberculosis and Johne’s disease.
News & Events
MRL Researcher, Dr. Ian Orme, is collaborating with the biopharmaceutical company GlobelImmune to create a new type of immunotherapeutic vaccine designed to prevent and treat tuberculosis. To learn more, read the article “CSU researcher and biopharmaceutical company seek tuberculosis treatment”
Leprosy Research in Brazil
Zoonotic TB Research
Dr. Francisco Olea-Popelka, a veterinary epidemiologist with the MRL, is the chairman of The Union’s Zoonotic TB Sub-Section. The sub-section monitors the transmission of tuberculosis between animals and people, especially in underserved communities in developing countries. To learn more, read the article in the Union E-News.